Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126558932 | 12655893 | 2 | F | 201608 | 20160818 | 20160816 | 20160819 | PER | US-PFIZER INC-2016387023 | PFIZER | 67.00 | YR | F | Y | 55.34000 | KG | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126558932 | 12655893 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | 20702 | 10 | MG | FILM-COATED TABLET | QD | ||||||
| 126558932 | 12655893 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0.05 MG, 1X/DAY | 0 | .05 | MG | QD | |||||||
| 126558932 | 12655893 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 2X/DAY | 0 | 40 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126558932 | 12655893 | 1 | Blood cholesterol increased |
| 126558932 | 12655893 | 2 | Thyroid disorder |
| 126558932 | 12655893 | 3 | Gastric disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126558932 | 12655893 | No adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126558932 | 12655893 | 1 | 201410 | 201602 | 0 |